PL364054A1 - Homogenizat dla implantów i mikrocząstek - Google Patents

Homogenizat dla implantów i mikrocząstek

Info

Publication number
PL364054A1
PL364054A1 PL02364054A PL36405402A PL364054A1 PL 364054 A1 PL364054 A1 PL 364054A1 PL 02364054 A PL02364054 A PL 02364054A PL 36405402 A PL36405402 A PL 36405402A PL 364054 A1 PL364054 A1 PL 364054A1
Authority
PL
Poland
Prior art keywords
microparticles
implants
homogenised product
homogenised
product
Prior art date
Application number
PL02364054A
Other languages
English (en)
Inventor
Gregor Schütz
Brigitte Freudensprung
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26009392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL364054(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE2001125509 external-priority patent/DE10125509A1/de
Priority claimed from DE2002108382 external-priority patent/DE10208382A1/de
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of PL364054A1 publication Critical patent/PL364054A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Steroid Compounds (AREA)
PL02364054A 2001-05-23 2002-05-23 Homogenizat dla implantów i mikrocząstek PL364054A1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2001125509 DE10125509A1 (de) 2001-05-23 2001-05-23 Lösungsmittelfreie Homogenisatherstellung
DE2002108382 DE10208382A1 (de) 2002-02-27 2002-02-27 Homogenisat für Implantate und Mikropartikel
PCT/EP2002/005680 WO2002094226A1 (de) 2001-05-23 2002-05-23 Homogenisat für implantate und mikropartikel

Publications (1)

Publication Number Publication Date
PL364054A1 true PL364054A1 (pl) 2004-12-13

Family

ID=26009392

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02364054A PL364054A1 (pl) 2001-05-23 2002-05-23 Homogenizat dla implantów i mikrocząstek

Country Status (16)

Country Link
US (1) US8501056B2 (pl)
EP (1) EP1392248B1 (pl)
JP (1) JP4346909B2 (pl)
AT (1) ATE369122T1 (pl)
BR (1) BR0209914A (pl)
CA (1) CA2449502C (pl)
CY (1) CY1106944T1 (pl)
CZ (1) CZ20033160A3 (pl)
DE (1) DE50210646D1 (pl)
DK (1) DK1392248T3 (pl)
ES (1) ES2290294T3 (pl)
NO (1) NO20035179D0 (pl)
PL (1) PL364054A1 (pl)
PT (1) PT1392248E (pl)
SK (1) SK14182003A3 (pl)
WO (1) WO2002094226A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1392248T3 (da) 2001-05-23 2007-11-12 Hexal Ag Fremgangsmåde til fremstilling af implantater ved oplösningsmiddelfri fremstilling af et homogenisat
FR2879075B1 (fr) * 2004-12-15 2007-01-19 Adisseo France Sas Soc Par Act Procede de preparation de granules de principe actif hydrophile par extrusion
FR2879074B1 (fr) * 2004-12-15 2007-08-03 Adisseo France Sas Soc Par Act Granules de principe actif hydrophile
CN101095941B (zh) * 2006-06-29 2011-04-20 北京博恩特药业有限公司 醋酸亮丙瑞林在预防和治疗老年性骨质疏松中的新用途
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
WO2010151746A2 (en) * 2009-06-26 2010-12-29 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
DE102011114864A1 (de) 2011-10-05 2013-04-11 Acino Ag Verfahren zur Herstellung einer homogenen Pulvermischung und Verfahren zur Herstellung eines Implantats sowie Implantat
WO2013065664A1 (ja) * 2011-10-31 2013-05-10 花王株式会社 化粧料
DE102013011399A1 (de) 2012-07-31 2014-02-06 Amw Gmbh Implantat mit Risperidon
WO2016076800A1 (en) * 2014-11-14 2016-05-19 Nanyang Technological University Bioresorbable-magnesium composite
USD782771S1 (en) 2015-04-03 2017-03-28 Geo Plastics Tight head drum
EP3492070A1 (en) 2017-11-30 2019-06-05 BIT Pharma GmbH Process and device for preparing a solid dispersion
USD938128S1 (en) 2020-01-06 2021-12-07 Geo Plastics Nestable drum
USD1001413S1 (en) 2020-06-30 2023-10-10 Geo Plastics Nestable drum

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992350A (en) * 1972-05-04 1976-11-16 Produits Chimiques Ugine Kuhlmann Process of mixing fillers with polytetrafluorethylene and tetrafluorethylene copolymers
US4016345A (en) * 1972-12-22 1977-04-05 E. I. Du Pont De Nemours And Company Process for polymerizing tetrafluoroethylene in aqueous dispersion
FR2418067A1 (fr) 1978-02-22 1979-09-21 Omya Sa Procede pour incorporer a un polymere des additifs solides, liquides ou pateux a temperature ambiante
DE3865133D1 (de) * 1987-07-10 1991-10-31 Karl Reinhard Zeiss Verfahren zur herstellung und zur verarbeitung von reaktionskunststoff-mischungen.
US4917834A (en) * 1988-11-16 1990-04-17 General Technology Applications, Inc. Method for forming homogeneous blends of particulate materials
CH679207A5 (pl) * 1989-07-28 1992-01-15 Debiopharm Sa
US5439688A (en) * 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
US5843347A (en) * 1993-03-23 1998-12-01 Laboratoire L. Lafon Extrusion and freeze-drying method for preparing particles containing an active ingredient
US5456917A (en) 1993-04-12 1995-10-10 Cambridge Scientific, Inc. Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
DE19545327C2 (de) 1995-12-05 2001-04-19 Fraunhofer Ges Forschung Verfahren zur Herstellung von hydrophobierten resorbierbaren Polyestern und deren Verwendung
US5817343A (en) * 1996-05-14 1998-10-06 Alkermes, Inc. Method for fabricating polymer-based controlled-release devices
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
US6177609B1 (en) * 1997-03-10 2001-01-23 Meadox Medicals, Inc. Self-aggregating protein compositions and use as sealants
WO1999009988A1 (en) * 1997-08-27 1999-03-04 Hexal Ag New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
US6455526B1 (en) * 1998-12-16 2002-09-24 Aventis Pharmaceuticals, Inc. Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same
KR100707710B1 (ko) 1998-12-16 2007-04-18 아벤티스 파마슈티칼스 인크. 생분해가능한 중합체로 캡슐화된 세로토닌 수용체 길항제및 이의 제조방법
US6291013B1 (en) 1999-05-03 2001-09-18 Southern Biosystems, Inc. Emulsion-based processes for making microparticles
DK1392248T3 (da) 2001-05-23 2007-11-12 Hexal Ag Fremgangsmåde til fremstilling af implantater ved oplösningsmiddelfri fremstilling af et homogenisat
US6712850B2 (en) * 2001-11-30 2004-03-30 Ethicon, Inc. Porous tissue scaffolds for the repair and regeneration of dermal tissue
US6894088B2 (en) * 2003-03-24 2005-05-17 Baker Hughes Incorporated Process for homogenizing polyolefin drag reducing agents

Also Published As

Publication number Publication date
CY1106944T1 (el) 2012-09-26
NO20035179D0 (no) 2003-11-21
US8501056B2 (en) 2013-08-06
ES2290294T3 (es) 2008-02-16
US20040173923A1 (en) 2004-09-09
EP1392248A1 (de) 2004-03-03
CA2449502A1 (en) 2002-11-28
EP1392248B1 (de) 2007-08-08
WO2002094226A1 (de) 2002-11-28
PT1392248E (pt) 2007-10-11
SK14182003A3 (sk) 2004-05-04
CA2449502C (en) 2010-10-12
JP4346909B2 (ja) 2009-10-21
JP2004530696A (ja) 2004-10-07
DK1392248T3 (da) 2007-11-12
BR0209914A (pt) 2004-04-06
CZ20033160A3 (en) 2004-03-17
ATE369122T1 (de) 2007-08-15
DE50210646D1 (de) 2007-09-20

Similar Documents

Publication Publication Date Title
CY1106944T1 (el) Μεθοδος για την παραγωγη εμφυτευματων μεσω παραγωγης - ανευ διαλυτων - ενος προϊοντος ομογενοποιησης
AU2002366083A1 (en) Matrix for the production of tissue engineered ligaments, tendons and other tissue
DE60011243D1 (de) Verfahren zur herstellung von mit antioxidant gedoptem uhmwpe und daraus hergestelltes implantat
AU2002358667A1 (en) Scented polymer capsules and the production thereof
AU2003230700A1 (en) Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
AU2002363933A1 (en) Nanogel networks including polyion polymer fragments and biological agent compositions thereof
WO2004011611A3 (en) Taci antibodies and uses thereof
WO2005074619A3 (en) Highly crystalline cross-linked oxidation-resistant polyethylene
WO2001015715A3 (en) Composition for maintenance of bone or dental health or treatment of bone or dental disorders
WO2003047646A8 (en) Resorbable polymer composition, implant and method of making implant
TR200003559A2 (tr) Hidrokolloit şekerleme ürünü
AU2003279567A1 (en) Sterilizing polymers and preparation and use thereof
AU2003251236A1 (en) Polyamide composition, process of preparation and use for making moulded articles
ATE286894T1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
MY134019A (en) Aryl oxime-piperazines useful as ccr5 antagonists
AU2003284691A1 (en) Calcium phosphate carrying protein, process for producing the same and sustained release protein preparation, artificial bone and tissue enginerring scaffold using the same
EP1051920A3 (en) Process for producing sesame products
AU3192299A (en) Improved implantable biomaterials, compositions and methods for their preparation and uses thereof
AU2002953568A0 (en) Novel chemical composition, method of making same, and products made therefrom
WO2002069944A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und nk1-rezeptor-antagonisten
AU2002251788A1 (en) Novel compounds and uses thereof
MXPA04006457A (es) Alcanosulfonamidas novedosas como antagonistas de endotelina.
WO2002040963A3 (en) Biologically active composites and methods for their production and use
AU2910800A (en) Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines
WO2003033512A3 (en) Method of preparing purified biologically active oligosaccharide libraries

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)